Private Equity
Industry figures have come out in defence both of financial engineering and the range and diversity of the asset class saying it does not depend on leverage for returns.
2 min read · 04 January 2013
The buyout firm is hoping the life insurer’s demands will bring forward discussions.
1 min read · 04 January 2013
The World Bank-backed investment company is looking to set up a body in partnership with another company to provide a gateway for investments into Africa.
1 min read · 04 January 2013
GLG, Goldman Sachs, and BlueMountain are first time investors in the ‘voice-to-screen’ messaging company.
2 min read · 04 January 2013
2 min read · 04 January 2013
Richard Laing, chief executive of the UK government-funded, emerging market fund of funds, sounded a note of caution as high valuations seem certain to hit future returns.
3 min read · 04 January 2013
2 min read · 04 January 2013
The South African mid-market outfit has closed its second fund, after returning the majority of its first fund to investors from just one exit.
1 min read · 04 January 2013
Biotechnology and life sciences companies require significant investment capital, and multi-million dollar investment rounds have recently grabbed headlines. But depending on the technologies being developed, the underlying research can be more or less expensive, providing many types of opportunities for investors. David Rapp spoke with leading biotech investors to learn more.
6 min read · 04 January 2013
The private equity group will take a stake in the German property lender following its admission in January that it was more exposed to the global credit crisis than previously thought.
1 min read · 04 January 2013
